DK162255C - Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf - Google Patents

Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Info

Publication number
DK162255C
DK162255C DK254585A DK254585A DK162255C DK 162255 C DK162255 C DK 162255C DK 254585 A DK254585 A DK 254585A DK 254585 A DK254585 A DK 254585A DK 162255 C DK162255 C DK 162255C
Authority
DK
Denmark
Prior art keywords
plunger pipe
preparation
plate
damper
aural
Prior art date
Application number
DK254585A
Other languages
English (en)
Other versions
DK254585A (da
DK162255B (da
DK254585D0 (da
Inventor
Ulrich Grau
Gerhard Ross
Dietrich Hiller
Horst Paul Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK254585D0 publication Critical patent/DK254585D0/da
Publication of DK254585A publication Critical patent/DK254585A/da
Publication of DK162255B publication Critical patent/DK162255B/da
Application granted granted Critical
Publication of DK162255C publication Critical patent/DK162255C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Steroid Compounds (AREA)
DK254585A 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf DK162255C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE3421615 1984-06-09
DE3421613 1984-06-09
DE3421613 1984-06-09
DE3421615 1984-06-09
DE19843443877 DE3443877A1 (de) 1984-06-09 1984-12-01 Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
DE3443877 1984-12-01

Publications (4)

Publication Number Publication Date
DK254585D0 DK254585D0 (da) 1985-06-06
DK254585A DK254585A (da) 1985-12-10
DK162255B DK162255B (da) 1991-10-07
DK162255C true DK162255C (da) 1992-03-16

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK254585A DK162255C (da) 1984-06-09 1985-06-06 Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf

Country Status (16)

Country Link
EP (1) EP0166971B1 (da)
AT (1) ATE50502T1 (da)
AU (1) AU575951B2 (da)
CA (1) CA1258427A (da)
DE (1) DE3576120D1 (da)
DK (1) DK162255C (da)
ES (1) ES8605679A1 (da)
FI (1) FI80596C (da)
GR (1) GR851393B (da)
HU (1) HU200102B (da)
IE (1) IE57998B1 (da)
IL (1) IL75448A (da)
NO (1) NO164277C (da)
NZ (1) NZ212338A (da)
PH (1) PH24118A (da)
PT (1) PT80620B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
LT2349324T (lt) 2008-10-17 2017-12-27 Sanofi-Aventis Deutschland Gmbh Insulino ir glp-1 agonisto derinys
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
PL2498801T3 (pl) 2009-11-13 2018-08-31 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę
HUE031181T2 (en) 2010-08-30 2017-06-28 Sanofi Aventis Deutschland Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
MY181626A (en) 2013-04-03 2020-12-29 Sanofi Sa Treatment of diabetes mellitus by long-acting formulations of insulins
US9950039B2 (en) 2014-12-12 2018-04-24 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
CA1176160A (en) * 1981-08-27 1984-10-16 Ronald E. Chance Human proinsulin pharmaceutical formulations
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
NO852314L (no) 1985-12-10
IL75448A (en) 1989-07-31
NO164277C (no) 1990-09-19
DK254585A (da) 1985-12-10
AU4342485A (en) 1985-12-12
ES543972A0 (es) 1986-01-16
DK162255B (da) 1991-10-07
IE57998B1 (en) 1993-06-02
EP0166971B1 (de) 1990-02-28
HUT37893A (en) 1986-03-28
FI80596C (fi) 1990-07-10
GR851393B (en) 1985-11-25
FI852273A0 (fi) 1985-06-06
AU575951B2 (en) 1988-08-11
FI80596B (fi) 1990-03-30
EP0166971A1 (de) 1986-01-08
HU200102B (en) 1990-04-28
ATE50502T1 (de) 1990-03-15
IE851431L (en) 1985-12-09
DE3576120D1 (de) 1990-04-05
PT80620B (pt) 1987-10-20
DK254585D0 (da) 1985-06-06
PT80620A (de) 1985-07-01
ES8605679A1 (es) 1986-01-16
PH24118A (en) 1990-03-05
FI852273L (fi) 1985-12-10
NZ212338A (en) 1989-02-24
IL75448A0 (en) 1985-10-31
CA1258427A (en) 1989-08-15
NO164277B (no) 1990-06-11

Similar Documents

Publication Publication Date Title
DK162255C (da) Vandigt insulinpraeparat og anvendelse af en kombination af stabiliserende, fysiologisk acceptable midler til fremstilling deraf
IT7869848A0 (it) Valvola per fluidi con strozzatore di flusso
KR880001454A (ko) 유체 충전 탄성중합체 댐핑장치
DK0702231T3 (da) Fremgangsmåde til pakning af chromatografikolonner
DE3882824T2 (de) Elastische Buchse mit Fluiddämpfung.
GB2240606B (en) Fluid filled elastomeric damping device
DK556487D0 (da) Gennemstroemningsvolumenmaaler til flydende medier
DE69010781D1 (de) Vorrichtung für die Thoraxdrainage.
DE3867204D1 (de) Gummilager.
DE59906300D1 (de) Fluidischer Stossdämpfer
ES2048369T3 (es) Tratamiento de metal liquido.
ATE67015T1 (de) Schwingungsdaempfer fuer maschinenlagerungen.
IT1138611B (it) Valvola di ritegno per fluidi
MY101782A (en) Method for removing a volatile material from a liquid and equipment for the working of this method
SU1334960A1 (ru) Сейсмоприемник
ES257901U (es) Cabeza tomamuestras para medidor de velocidad de sedimenta- cion de sangre
JPS56116938A (en) Buffer
UA39943C2 (uk) Компенсатор енергії
SE8504611D0 (sv) Vattenpump
SE8603824L (sv) Leckageindikator
IT8041572A0 (it) Procedimento per determinare la profondita&#39; di giacitura di uno strato saturo di fluido e il tipo di fluido.
SE8400668D0 (sv) Massageapparat
JPS57157843A (en) Mounting method of rebound rubber in damper
ES262731U (es) Soporte de motor de dos camaras con amortiguacion hidraulica.
UA8634A1 (uk) Спосіб видалеhhя рідиhи з вибою свердловиhи

Legal Events

Date Code Title Description
PUP Patent expired